| LDR | 01467nam a2200349Ia 4500 | ||
| 001 | 101805880 | ||
| 003 | MiAaHDL | ||
| 005 | 20170119000000.0 | ||
| 006 | m d | ||
| 007 | cr bn ---auaua | ||
| 008 | 000519s1999 gau b f000 0 eng d | ||
| 035 | ⊔ | ⊔ | ‡asdr-osu.b52217905 |
| 035 | ⊔ | ⊔ | ‡a.b52217905 |
| 040 | ⊔ | ⊔ | ‡aFNP ‡cFNP ‡dWaOLN |
| 049 | ⊔ | ⊔ | ‡aOHLM |
| 086 | 0 | ⊔ | ‡aHE 20.7009:48/RR-14 |
| 090 | ⊔ | ⊔ | ‡aRA644.I6 ‡bN45 1999 |
| 090 | ⊔ | ⊔ | ‡aRA644.I6 ‡bN45 1999 |
| 035 | ⊔ | ⊔ | ‡a(OCoLC)44084956 |
| 245 | 0 | 0 | ‡aNeuraminidase inhibitors for treatment of influenza A and B infections. |
| 260 | ⊔ | ⊔ | ‡aAtlanta, Ga. : ‡bU.S. Dept. of Health and Human Services, Centers for Disease Control and Prevention (CDC) ; ‡b[available from] Supt. of Docs., U.S. G.P.O., ‡c1999. |
| 300 | ⊔ | ⊔ | ‡aii, 10 p. ; ‡c22 cm. |
| 490 | 0 | ⊔ | ‡aMorbidity and mortality weekly report. Recommendations and reports ; ‡vv. 48, no. RR-14 (Dec. 17, 1999) |
| 500 | ⊔ | ⊔ | ‡aCover title. |
| 504 | ⊔ | ⊔ | ‡aBibliography: p. 7-9. |
| 538 | ⊔ | ⊔ | ‡aMode of access: Internet. |
| 650 | ⊔ | 0 | ‡aInfluenza ‡xTreatment ‡zUnited States. |
| 650 | ⊔ | 0 | ‡aInfluenza ‡zUnited States ‡xPrevention. |
| 650 | ⊔ | 0 | ‡aInfluenza viruses ‡zUnited States. |
| 650 | ⊔ | 0 | ‡aNeuraminidase ‡xTherapeutic use. |
| 650 | ⊔ | 0 | ‡aInfluenza vaccines ‡zUnited States. |
| 710 | 2 | ⊔ | ‡aCenters for Disease Control and Prevention (U.S.) |
| CID | ⊔ | ⊔ | ‡a101805880 |
| DAT | 0 | ⊔ | ‡a20000912124059.7 ‡b20170119000000.0 |
| DAT | 1 | ⊔ | ‡a20170120090809.0 ‡b2023-08-15T18:13:46Z |
| DAT | 2 | ⊔ | ‡a2023-08-15T17:30:02Z |
| CAT | ⊔ | ⊔ | ‡aSDR-OSU ‡dIII - SIERRA ‡lprepare.pl-004-007 |
| FMT | ⊔ | ⊔ | ‡aBK |
| HOL | ⊔ | ⊔ | ‡0sdr-osu.b52217905 ‡aosu ‡bSDR ‡cOSU ‡posu.32437011396237 ‡sOU ‡1.b52217905 |
| 974 | ⊔ | ⊔ | ‡bOU ‡cOSU ‡d20230815 ‡sgoogle ‡uosu.32437011396237 ‡y1999 ‡rpd ‡qbib ‡tUS fed doc |